NASDAQ: MURAMural Oncology PLC Stock Ownership - Who owns Mural Oncology?
Insider buying vs selling
Have Mural Oncology PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Maiken Kesonbrookes | Chief Legal Officer and Secretary | 2024-12-23 | 2,555 | $3.27 | $8.35kSell |
| Caroline Loew | Chief Executive Officer | 2024-12-17 | 2,763 | $3.40 | $9.39kSell |
| Vicki L. Goodman | Chief Medical Officer | 2024-11-07 | 5,069 | $3.33 | $16.88kSell |
| Adam D. Cutler | Chief Financial Officer | 2024-10-31 | 7,421 | $3.41 | $25.31kSell |
| Susan Altschuller | Director | 2024-08-14 | 10,000 | $3.21 | $32.07kBuy |
| Maiken Kesonbrookes | Chief Legal Officer and Secretary | 2024-07-18 | 2,157 | $3.41 | $7.36kSell |
| Caroline Loew | Chief Executive Officer | 2024-07-08 | 12,531 | $2.91 | $36.47kSell |
MURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MURA insiders and whales buy or sell their stock.
MURA Shareholders
What type of owners hold Mural Oncology PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 9.96% | 1,700,000 | $6.27M | Institution |
| Solas Capital Management LLC | 7.44% | 1,269,000 | $4.68M | Institution |
| Vanguard Group Inc | 4.90% | 835,589 | $3.08M | Institution |
| Alta Fundamental Advisers LLC | 4.22% | 720,143 | $2.66M | Institution |
| Prosight Management LP | 3.34% | 570,620 | $2.11M | Institution |
| Newtyn Management LLC | 3.34% | 570,000 | $2.10M | Institution |
| Acadian Asset Management LLC | 2.24% | 381,404 | $1.41M | Institution |
| Rbf Capital LLC | 2.11% | 359,900 | $1.33M | Institution |
| Blackrock Inc 1 | 2.03% | 346,154 | $1.28M | Institution |
| Blackrock Inc | 2.03% | 346,154 | $1.28M | Institution |
MURA vs Biotech Stocks
Mural Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.